The impact of the COVID-19 pandemic on time to treatment in head and neck cancer management: a systematic review
DOI:
https://doi.org/10.2340/1651-226X.2025.41366Keywords:
Time to treatment initiation, tumor stage, delay, waiting timeAbstract
Background and purpose: Coronavirus disease 2019 (COVID-19) caused a need for reorganization in the healthcare systems. First, we aimed to determine the impact of the COVID-19 pandemic on time to treatment in head and neck cancer (HNC) patients. Second, we aimed to determine the impact of COVID-19 on tumor stage and changes in treatment regimens used.
Material and methods: A systematic search in PubMed and Embase was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Inclusion criteria were: (1) Studies including patients with head and neck squamous cell carcinomas; (2) Studies containing a comparison of time to treatment; (3) Studies containing a well-defined time interval with restrictions on health care due to COVID-19 and a well-defined time interval without restrictions.
Results: A total of 19 studies were included comprising 24,898 patients treated for HNC cancer. Six studies (10.1% of the patients) reported an increase in waiting time within at least one interval, while seven studies reported a decrease (83.2% of the patients), and six studies found no significant effect. No changes in treatment modalities were observed. Seven of 15 studies (12.7% of the patients) observed an increase in either overall stage, size, or tumor node and metastasis classification during the COVID-19 pandemic. Among these, two studies reported increased waiting times as well.
Interpretation: The impact of the COIVD-19 pandemic on time to treatment was heterogenous and subject to considerable intercountry and interregional variations. A tendency toward a higher T-classification was observed. In conclusion, otorhinolaryngology departments demonstrated resilience, as the pandemic led to only slight alterations in time to treatment.
Downloads
References
World Health Organisation. Emergency overview, Coronavirus disease (COVID-19) pandemic. Available from: https://www.who.int/europe/emergencies/situations/covid-19
Brindle ME, Gawande A. Managing COVID-19 in surgical systems. Ann Surg. 2020;272(1):e1–2.
https://doi.org/10.1097/SLA.0000000000003923 DOI: https://doi.org/10.1097/SLA.0000000000003923
Emanuel EJ, Persad G, Upshur R, Thome B, M.P.H., Michael P, et al. Fair allocation of scarce medical resources in the time of covid-19. N Engl J Med. 2020;382(21): 2049–55.
https://doi.org/10.1056/NEJMsb2005114 DOI: https://doi.org/10.1056/NEJMsb2005114
World Health Organisation. Pulse survey on continuity of essential health services during the COVID-19 pandemic: interim report, 27 August 2020. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-EHS_continuity-survey-2020.1
Matenge S, Sturgiss E, Desborough J, Hall Dykgraaf S, Dut G, Kidd M. Ensuring the continuation of routine primary care during the COVID-19 pandemic: a review of the international literature. Fam Pract. 2022;39(4):747–61.
https://doi.org/10.1093/fampra/cmab115 DOI: https://doi.org/10.1093/fampra/cmab115
Heymann DL, Shindo N. COVID-19: what is next for public health? Lancet. 2020;395(10224):542–5.
https://doi.org/10.1016/S0140-6736(20)30374-3 DOI: https://doi.org/10.1016/S0140-6736(20)30374-3
Brindle ME, Doherty G, Lillemoe K, Gawande A. Approaching surgical triage during the COVID-19 pandemic. Ann Surg. 2020;272(2):e40–2.
https://doi.org/10.1097/SLA.0000000000003992 DOI: https://doi.org/10.1097/SLA.0000000000003992
Mehanna H, Hardman JC, Shenson JA, Abou-Foul AK, Topf MC, AlFalasi M, et al. Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensus. Lancet Oncol. 2020;21(7):e350–9.
https://doi.org/10.1016/S1470-2045(20)30334-X DOI: https://doi.org/10.1016/S1470-2045(20)30334-X
American College of Surgeons. COVID 19: Elective Case Triage Guidelines for Surgical Care, 12/8 2020. Available from: https://www.facs.org/media/33km00ma/guidance_for_triage_of_nonemergent_surgical_procedures_general_surgery.pdf
OECD/European Union (2020). Health at a Glance: Europe 2020: State of Health in the EU Cycle, OECD Publishing, Paris.
https://doi.org/10.1787/82129230-en. DOI: https://doi.org/10.1787/82129230-en
Abdelrahman H, Atteya S, Ihab M, Nyan M, Maharani AD, Rahardjo A, et al. Dental practice closure during the first wave of COVID-19 and associated professional, practice and structural determinants: a multi-country survey. BMC Oral Health. 2021;21(1):243.
https://doi.org/10.1186/s12903-021-01601-4 DOI: https://doi.org/10.1186/s12903-021-01601-4
Thomson DJ, Palma D, Guckenberger M, Balermpas P, Beitler JJ, Blanchard P, et al. Practice recommendations for risk-adapted head and neck cancer radiation therapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement. Int J Radiat Oncol Biol Phys. 2020;107(4):618–27.
https://doi.org/10.1016/j.ijrobp.2020.04.016 DOI: https://doi.org/10.1016/j.ijrobp.2020.04.016
Graboyes EM, Kompelli AR, Neskey DM, Brennan E, Nguyen S, Sterba KR, et al. Association of treatment delays with survival for patients with head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2019;145(2):166.
https://doi.org/10.1001/jamaoto.2018.2716 DOI: https://doi.org/10.1001/jamaoto.2018.2716
Schutte HW, Heutink F, Wellenstein DJ, van den Broek GB, van den Hoogen FJA, Marres HAM, et al. Impact of time to diagnosis and treatment in head and neck cancer: a systematic review. Otolaryngol Head Neck Surg. 2020;162(4):446–57.
https://doi.org/10.1177/0194599820906387 DOI: https://doi.org/10.1177/0194599820906387
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
https://doi.org/10.1136/bmj.n71 DOI: https://doi.org/10.1136/bmj.n71
Downes MJ, Brennan ML, Williams HC, Dean RS. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open. 2016;6(12):e011458.
https://doi.org/10.1136/bmjopen-2016-011458 DOI: https://doi.org/10.1136/bmjopen-2016-011458
Gršić K. The impact of COVID-19 on head and neck cancer treatment delay. Acta Clin Croat. 2022;61(Suppl. 4):19–25.
https://doi.org/10.20471/acc.2022.61.s4.2 DOI: https://doi.org/10.20471/acc.2022.61.s4.2
ZZubair A, Jamshaid S, Scholfield DW, Hariri AA, Ahmed J, Ghufoor K, et al. Impact of COVID-19 pandemic on head-neck cancer referral and treatment pathway in North East London. Ann R Coll Surg Engl. 2023;105(S2):S28–34.
https://doi.org/10.1308/rcsann.2021.0360 DOI: https://doi.org/10.1308/rcsann.2021.0360
Lucidi D, Valerini S, Federici G, Miglio M, Cantaffa C, Alicandri-Ciufelli M. Head and neck cancer during covid-19 pandemic: was there a diagnostic delay? Indian J Otolaryngol Head Neck Surg. 2022;74(S2):3245–51.
https://doi.org/10.1007/s12070-021-03050-5 DOI: https://doi.org/10.1007/s12070-021-03050-5
Schoonbeek RC, de Jel DVC, van Dijk BAC, Willems SM, Bloemena E, Hoebers FJP, et al. Fewer head and neck cancer diagnoses and faster treatment initiation during COVID-19 in 2020: a nationwide population-based analysis. Radiother Oncol. 2022;167:42–8.
https://doi.org/10.1016/j.radonc.2021.12.005 DOI: https://doi.org/10.1016/j.radonc.2021.12.005
Meerwein CM, Stadler TM, Balermpas P, Soyka MB, Holzmann D. Diagnostic pathway and stage migration of sinonasal malignancies in the era of the COVID‐19 pandemic. Laryngoscope Investig Otolaryngol. 2021;6(5):904–10.
https://doi.org/10.1002/lio2.640 DOI: https://doi.org/10.1002/lio2.640
Tevetoğlu F, Kara S, Aliyeva C, Yıldırım R, Yener HM. Delayed presentation of head and neck cancer patients during COVID-19 pandemic. Eur Arch Oto Rhino Laryngol. 2021;278(12):5081–5.
https://doi.org/10.1007/s00405-021-06728-2 DOI: https://doi.org/10.1007/s00405-021-06728-2
Psycharis SS, Salameh S, Turkdogan S, et al. Prioritization of head and neck cancer patient care during the COVID-19 pandemic: a retrospective cohort study. J Otolaryngol Head Neck Surg. 2023;52(1):15.
https://doi.org/10.1186/s40463-023-00625-w DOI: https://doi.org/10.1186/s40463-023-00625-w
Solis RN, Mehrzad M, Faiq S, Frusciante RP, Sekhon HK, Abouyared M, et al. The impact of COVID‐19 on head and neck cancer treatment: before and during the pandemic. OTO Open. 2021;5(4):2473974X211068075.https://doi.org/10.1177/2473974X211068075 DOI: https://doi.org/10.1177/2473974X211068075
Heckel S, Bohr C, Meier J, Maurer J, Kuenzel J, Mueller K, et al. Head and neck oncology management in the time of COVID-19: results of a head and neck cancer center. J Cancer Res Clin Oncol. 2023;149(13):12081–7. https://doi.org/10.1007/s00432-023-05122-1 DOI: https://doi.org/10.1007/s00432-023-05122-1
Metzger K, Mrosek J, Zittel S, Pilz M, Held T, Adeberg S, et al. Treatment delay and tumor size in patients with oral cancer during the first year of the COVID‐19 pandemic. Head Neck. 2021;43(11):3493–7.
https://doi.org/10.1002/hed.26858 DOI: https://doi.org/10.1002/hed.26858
AAbelardo E, Gravelle R, Scannell M, Shastri P, Vandekar M, Davies G, et al. Impact of coronavirus disease 2019 on head and neck urgent suspected cancer referral pathways in rural Wales. J Laryngol Otol. 2022;136(6):540–6.
https://doi.org/10.1017/S002221512200069X DOI: https://doi.org/10.1017/S002221512200069X
Tasoulas J, Schrank TP, Smith BD, Agala CB, Kim S, Sheth S, et al. Time to treatment patterns of head and neck cancer patients before and during the Covid-19 pandemic. Oral Oncol. 2023;146:106535.
https://doi.org/10.1016/j.oraloncology.2023.106535 DOI: https://doi.org/10.1016/j.oraloncology.2023.106535
Drake I, Rogers A, Stewart M, Montgomery J. The impact of coronavirus disease 2019 on the head and neck cancer pathway in the West of Scotland. J Laryngol Otol. 2022;136(6):535–9.
https://doi.org/10.1017/S0022215122000603 DOI: https://doi.org/10.1017/S0022215122000603
Yao P, Cooley V, Kuhel W, Tassler A, Banuchi V, Long S, et al. Times to diagnosis, staging, and treatment of head and neck cancer before and during COVID‐19. OTO Open. 2021;5(4):2473974X211059429 https://doi.org/10.1177/2473974X211059429 DOI: https://doi.org/10.1177/2473974X211059429
Yang Y, Shen C, Hu C. Effect of COVID-19 epidemic on delay of diagnosis and treatment path for patients with nasopharyngeal carcinoma. Cancer Manag Res. 2020;12:3859–64.
https://doi.org/10.2147/CMAR.S254093 DOI: https://doi.org/10.2147/CMAR.S254093
Stevens MN, Patro A, Rahman B, Gao Y, Liu D, Cmelak A, et al. Impact of COVID-19 on presentation, staging, and treatment of head and neck mucosal squamous cell carcinoma. Am J Otolaryngol. 2022;43(1):103263.
https://doi.org/10.1016/j.amjoto.2021.103263 DOI: https://doi.org/10.1016/j.amjoto.2021.103263
Kiong KL, Diaz EM, Gross ND, Diaz EM, Hanna EY. The impact of COVID‐19 on head and neck cancer diagnosis and disease extent. Head Neck. 2021;43(6):1890–7.
https://doi.org/10.1002/hed.26665 DOI: https://doi.org/10.1002/hed.26665
Heimes D, Müller LK, Schellin A, Naujokat H, Graetz C, Schwendicke F, et al. Consequences of the COVID-19 pandemic and governmental containment policies on the detection and therapy of oral malignant lesions – a retrospective, multicenter cohort study from Germany. Cancers (Basel). 2021;13(12):2892.
https://doi.org/10.3390/cancers13122892 DOI: https://doi.org/10.3390/cancers13122892
Kourtidis S, Münst J, Hofmann VM. Effects of the COVID-19 pandemic on head and neck cancer stage and treatment duration. Cureus. 2022;14(7):e26744.
https://doi.org/10.7759/cureus.26744 DOI: https://doi.org/10.7759/cureus.26744
World Health Organisation. Number of physicians (per 10 000 population) including generalists, specialist medical practitioners and medical doctors not further defined. Available from: https://data.who.int/indicators/i/CCCEBB2/217795A
World Health Organisation. Number of COVID-19 cases reported to WHO. Available from: https://covid19.who.int/
Ali JK, Riches JC. The impact of the COVID-19 pandemic on oncology care and clinical trials. Cancers (Basel). 2021;13(23):5924.
https://doi.org/10.3390/cancers13235924 DOI: https://doi.org/10.3390/cancers13235924
Mo Y, Eyre DW, Lumley SF, Walker TM, Shaw RH, O’Donnell D, et al. Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: a cohort study. PLoS Med. 2021;18(10):e1003816.
https://doi.org/10.1371/journal.pmed.1003816 DOI: https://doi.org/10.1371/journal.pmed.1003816
SSpencer K, Jones CM, Girdler R, Roe C, Sharpe M, Lawton S, et al. The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study. Lancet Oncol. 2021;22(3):309–20.
https://doi.org/10.1016/S1470-2045(20)30743-9 DOI: https://doi.org/10.1016/S1470-2045(20)30743-9
Dinmohamed AG, Visser O, Verhoeven RHA, Louwmana MWJ, van Nederveenj FH, Willems SM, et al. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol. 2020;21(6):750–1.
https://doi.org/10.1016/S1470-2045(20)30265-5 DOI: https://doi.org/10.1016/S1470-2045(20)30265-5
Howlader N, Bhattacharya M, Scoppa S, Miller D, Noone A-M, Negoita S, et al. Cancer and COVID19: US cancer incidence rates during the first year of the pandemic. J Natl Cancer Inst. 2024;116(2):208–15. https://doi.org/10.1093/jnci/djad205 DOI: https://doi.org/10.1093/jnci/djad205
Decker KM, Feely A, Bucher O, Czaykowski P, Hebbard P, Kim JO, et al. New cancer diagnoses before and during the COVID-19 pandemic. JAMA Netw Open. 2023;6(9):e2332363.
https://doi.org/10.1001/jamanetworkopen.2023.32363 DOI: https://doi.org/10.1001/jamanetworkopen.2023.32363
Du E, Mazul AL, Farquhar D, Anantharaman D, Abedi-Ardekani B, Weissler MC, et al. Long‐term survival in head and neck cancer: impact of site, stage, smoking, and human papillomavirus status. Laryngoscope. 2019;129(11):2506–13.
https://doi.org/10.1002/lary.27807 DOI: https://doi.org/10.1002/lary.27807
Pierik AS, Leemans CR, Brakenhoff RH. Resection margins in head and neck cancer surgery: an update of residual disease and field cancerization. Cancers (Basel). 2021;13(11):2635.
https://doi.org/10.3390/cancers13112635 DOI: https://doi.org/10.3390/cancers13112635
Burnet NG. Defining the tumour and target volumes for radiotherapy. Cancer Imaging. 2004;4(2):153–161.
https://doi.org/10.1102/1470-7330.2004.0054 DOI: https://doi.org/10.1102/1470-7330.2004.0054
Additional Files
Published
How to Cite
License
Copyright (c) 2025 Malte Grumstrup Simonsen, Amanda-Louise Fenger Carlander, Kathrine Kronberg Jakobsen, Christian Grønhøj, Christian von Buchwald
This work is licensed under a Creative Commons Attribution 4.0 International License.
